Summary
Insulin resistance and a defective insulin activation of the enzyme glycogen synthase in skeletal muscle during euglycaemia may have important pathophysiological implications in Type 2 (non-insulin-dependent) diabetes mellitus. Hyperglycaemia may serve to compensate for these defects in Type 2 diabetes by increasing glucose disposal through a mass action effect. In the present study, rates of whole-body glucose oxidation and glucose storage were measured during fasting hyperglycaemia and isoglycaemic insulin infusion (40 mU·m−2min−1, 3 h) in 12 patients with Type 2 diabetes. Eleven control subjects were studied during euglycaemia. Biopsies were taken from the vastus lateralis muscle. Fasting and insulin-stimulated glucose oxidation, glucose storage and muscle glycogen synthase activation were all fully compensated (normalized) during hyperglycaemia in the diabetic patients. The insulin-stimulated increase in muscle glycogen content was the same in the diabetic patients and in the control subjects. Besides hyperglycaemia, the diabetic patients had elevated muscle free glucose and glucose 6-phosphate concentrations. A positive correlation was demonstrated between intracellular free glucose concentration and muscle glycogen synthase fractional velocity insulin activation (0.1 mmol/l glucose 6-phosphate: r=0.65, p<0.02 and 0.0 mmol/l glucose 6-phosphate: r= 0.91, p<0.0001). In conclusion, this study indicates an important role for hyperglycaemia and elevated muscle free glucose and glucose 6-phosphate concentrations in compensating (normalizing) intracellular glucose metabolism and skeletal muscle glycogen synthase activation in Type 2 diabetes.
Article PDF
Similar content being viewed by others
References
DeFronzo R, Deibert D, Hendler R, Felig P, Soman V (1979) Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest 63: 939–946
Kolterman O, Gray R, Griffin J et al. (1981) Receptor and post-receptor defects contribute to the insulin resistance in non-insulin dependent diabetes mellitus. J Clin Invest 68: 957–969
DeFronzo R, Gunnarson R, Björkman O, Olsson M, Wahren J (1985) Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type 2) diabetes mellitus. J Clin Invest 76: 149–155
Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H (1990) Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 diabetes. Diabetologia 34: 239–245
Meyer HU, Curchod B, Maeder P, Pahud E, Jequier E, Felber JP (1980) Modifications of glucose storage and oxidation in non-obese diabetics, measured by continuous indirect calorimetry. Diabetes 29: 752–756
Boden G, Ray TK, Smith RH, Owen OE (1983) Carbohydrate oxidation and storage rates in obese non-insulin dependent diabetic patients. Effect of improving glycaemic control. Diabetes 32: 982–987
Golay A, DeFronzo RA, Ferrannini E et al. (1988) Oxidative and non-oxidative glucose metabolism in non-obese Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 585–591
Kelley DE, Mandarino LJ (1990) Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in non-insulin-dependent diabetes mellitus. J Clin Invest 86: 1999–2007
Leloir LF, Olavaria JM, Goldenberg SH, Carminatti H (1959) Biosynthesis of glycogen from uridine diphosphate glucose. Arch Biochem Biophys 81: 508–520
Mandarino L, Wright K, Verity et al. (1987) Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. J Clin Invest 80: 655–663
Villar-Palasi C, Larner J (1960) Insulin-mediated effect on the activity of UDPG-glycogen transglucosylase of muscle. Biochim Biophys Acta 81: 508–520
Bogardus C, Lillioja S, Stone K, Mott D (1984) Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73: 1185–1190
Johnson AB, Argyraki M, Thow JC, Brougthon D, Jones IR, Taylor R (1990) Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Diab Med 7: 420–428
Revers RR, Fink R, Griffin J, Olefsky JM, Kolternman OG (1984) Influence of hyperglycemia on insulin's in vivo effects in type 11 diabetes. J Clin Invest 73: 664–672
McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 55: 628–634
Hother-Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with Type 2 (non-insulin-dependent) diabetes using primed-continuous 3-3H-glucose infusion. Diabetologia 33: 603–610
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 41: 565–573
Ferrannini E (1983) The theoretical basis of indirect calorimetry: a review. Metabolism 37: 287–301
Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37: 1212–1216
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430
Cowan JS, Hetenyi S (1971) Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. Metabolism 20: 360–372
Cobelli C, Mari A, Ferrannini E (1987) Non-steady state: error analysis of Steele's model and development for glucose kinetics. Am J Physiol 252: E679-E689
Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810–817
Lowry OH, Passoneau JV (1972) A flexible system of enzymatic analysis. Academic Press, New York
Sjøgaard G, Adams RP, Saltin B (1985) Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol 248: R190-R196
Sjøgaard G, Saltin B (1982) Extraand intracellular water spaces in muscles in man at rest and with dynamic exercise. Am J Physiol 243: R271-R280
Thomas J, Schlender K, Larner J (1968) A rapid filter paper assay for UDP-glucose-glycogen gluco-syltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25: 486–499
Eowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with Folin phenol reagent. J Biol Chem 193: 265–272
Andersen I, Hannibal S (1983) Analytical and economical optimization of a glucose method with immobilized enzymes. J Automatic Chem 5: 188–192
Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8: 260–266
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Itaya K, Michio U (1965) Colorimetric determination of free fatty acids in biological fluids. J Eipid Res 6: 16–20
Passonneau JV (1974) L-(+)-lactate. Fluorometric method. In: Bergmeyer HV (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1468–1472
Mortensen HB (1980) Quantitative determination of hemoglobin A1c by thin layer isoelectric focusing. J Chromatogr 182: 325–333
Thorburn AW, Gumbiner B, Bulcan F, Wallace P, Henry RR (1990) Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (Type II) diabetes independent of impaired glucose uptake. J Clin Invest 85: 522–529
Thorburn AW, Gumbiner B, Bulcan F, Brechtel G, Henry RR (1991) Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87: 489–495
Mandarino LJ, Consoli A, Kelley DE, Reilly JJ, Nurjhan N (1990) Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 71: 1544–1551
Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Ravussin E, Bogardus C, Schwartz RS et al. (1983) Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Invest 72: 893–902
Golay A, Felber JP, Jequier E, DeFronzo RA, Ferrannini E (1988) Metabolic basis of obesity and non-insulin-dependent diabetes mellitus. Diab Metab Rev 4: 727–747
DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000–1007
Yki-Järvinen H, Mott D, Young AA, Stone K, Bogardus C (1987) Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest 80: 95–100
Vaag A, Damsbo P, Skött P, Richter EA (1990) Effect of hyperglycemia per se on glucose metabolism in skeletal muscles in patients with IDDM. Diabetes 39 [Suppl 1]: 14A (Abstract)
Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant Type 1 diabetic patients. Diabetes 30: 157–167
Le Marchand-Brustel Y, Freychet P (1981) Regulation of glycogen synthase activity in the isolated mouse soleus muscle. Effect of insulin, epinephrine, glucose and antiinsulin receptor antibodies. Biochim Biophy Acta 677: 13–22
Oron Y, Larner J (1972) Insulin action in intact mouse diaphragm. I. Activation of glycogen sythase through stimulation of sugar transport and phosphorylation. Mol Cell Biochem 32: 153–160
Rosell-Perez M, Villar-Palasci C, Larner J (1962) Studies on UDPG-glycogen transglycosylase. I. Preparation and differentiation of two activities of UDPG-glycogen transglucosylase from rat skeletal. Biochemistry 2: 669–675
Friedman DL, Larner J (1963) Studies on UDPG-beta-glucan transglucosylase. III. Interconversion of two forms of muscle UDPG-beta-glucan transglucosylase by a phosphorylation-dephosphorylation reaction sequence. Biochemistry 2: 669–675
Rossetti L, Giaccari A (1990) Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85: 1785–1792
Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished beta-cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 74: 1318–1328
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaag, A., Damsbo, P., Hother-Nielsen, O. et al. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35, 80–88 (1992). https://doi.org/10.1007/BF00400856
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400856